––––––––––––––––––––
Subscribe to the Legal News!
https://www.legalnews.com/Home/Subscription
Full access to public notices, articles, columns, archives, statistics, calendar and more
Day Pass Only $4.95!
One-County $80/year
Three-County & Full Pass also available
- Posted May 07, 2012
- Tweet This | Share on Facebook
Ann Arbor attorney publishes article on patent reform
Eric Sosenko, a shareholder in the Ann Arbor office of Brinks Hofer Gilson & Lione, and chair of Brinks' Patent Reform Task Force, has published an article on how patent reform in the America Invents Act (AIA) will impact the medical device industry.
The article, titled "Patent Reform: Is the Cure Worse than the Disease?" was published in the April 19 edition of MX, a publication of the Medical Device and Diagnostic Industry.
The thesis of Sosenko's article is that first-to-file and prior art revisions of the AIA, which take effect March 16, 2013, will impact the patent strategies of medical device companies. Further, given the rapid pace of innovation in the medical technology field, companies in the near future will be pressured to file patent applications as quickly as possible in order to maintain competitive advantage.
The article can be read at http://www.mddionline.com/article/patent-reform-cure-worse-disease.
Published: Mon, May 7, 2012
headlines Washtenaw County
- MSU Law celebrates 25 years of the Geoffrey Fieger Trial Practice Institute
- Marching on: Expert in liquor law overcomes more than her share of hurdles
- The time has come to put an end to electoral vote in U.S.
- Business helps clients take empowering step forward
- Stride for Justice charity event slated for April 18
headlines National
- Exodus: Thousands of federal lawyers left their jobs by choice or by force in 2025
- Wisconsin moves to UBE to ease access-to-justice woes
- The Burton Book Review: A discussion on ‘When You Come at the King’
- Facebook, Instagram pulling ads from lawyers looking for plaintiffs ... to sue them
- Florida law school pressed to include chapter of Charlie Kirk’s Turning Point USA
- BigLaw firm faces questions over $35M bill




